Segment featuring leading Neuro-Oncologist and Glioblastoma Key Opinion Leader, Professor Michael Weller Access the segment here HOUSTON, TX / ACCESSWIRE / November 4, 2024 / CNS Pharmaceuticals, Inc.
HOUSTON, TX / ACCESSWIRE / November 1, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for prim
SAN FRANCISCO--(BUSINESS WIRE)--Elastic (NYSE: ESTC), the Search AI company, today announced its successful collaboration with LG CNS, a leading digital transformation company in Korea, to help transf
SmartWall ONE ™  Named a Hot Company DDoS Protection Solution by Cyber Defense Magazine MARLBOROUGH, Mass. , Oct. 31, 2024 /PRNewswire/ -- Corero Network Security (AIM: CNS) (OTCQB: DDoSF), the dis
NEW YORK , Oct. 30, 2024 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers REIT and Preferred and Income Fund, Inc. (NYSE: RNP) (the "Fund") with information regarding the so
NEW YORK , Oct. 30, 2024 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Total Return Realty Fund, Inc. (NYSE: RFI) (the "Fund") with information regarding the sources of t
NEW YORK , Oct. 30, 2024 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Quality Income Realty Fund, Inc. (NYSE: RQI) (the "Fund") with information regarding the sources of
NEW YORK , Oct. 30, 2024 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Infrastructure Fund, Inc. (NYSE: UTF) (the "Fund") with information regarding the sources of the di
NEW YORK , Oct. 30, 2024 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Closed-End Opportunity Fund, Inc. (NYSE: FOF) (the "Fund") with information regarding the sources of
NEW YORK , Oct. 30, 2024 /PRNewswire/ -- Cohen & Steers (NYSE: CNS) announced today that funds managed by the Private Real Estate Group of Cohen & Steers and DLC, an owner and operator of open-air sho
NEW YORK , Oct. 29, 2024 /PRNewswire/ -- Cohen & Steers (NYSE: CNS) announced today that funds managed by the Private Real Estate Group of Cohen & Steers and the Investment Management business of Acad
New Platform Provides Real-Time Traffic Analytics, Threat Intelligence, Application Layer Protection, and Anti-Bot DDoS Defense To Enhance Service Availability and Security MARLBOROUGH, Mass. , Oct.
Customers Seeking Appliance Upgrades Can Trade in Existing Hardware MARLBOROUGH, Mass. , Oct. 24, 2024 /PRNewswire/ -- Corero Network Security (AIM: CNS) (OTCQB: DDOSF), the distributed denial of ser
HOUSTON, TX / ACCESSWIRE / October 23, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for prim
Cohen & Steers' Q3 2024 results exceeded expectations, with revenue up 9.4% YoY and non-GAAP adjusted EPS up 13.5% YoY. Significant AUM growth and a return to positive net inflows drove the strong fin
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE